In turn, Jing et al. [203] carried out studies on albumin-based nanocomposites incorporated with N5,N6-Bis(2-fluorophenyl)[1,2,5]oxadiazolo[3,4-b]pyrazine-5,6-diamine (BAM15), an active substance that may prevent obesity and its potential symptoms. The gene discussed is ALB; the disease is obesity disorder.